What have been the newest developments in digital R&D and lab automation, patient-centric design, digitalised manufacturing and provide chains? Highlighting the rise of a sensible pharma, AUTOMA+ 2025 happened in Vösendorf, Austria on 24-25 November. The occasion was a dynamic interaction of know-how, options and forward-thinking concepts.
Whereas all improvements have been in a single venue, their affect extends worldwide. The Pharmaceutical Automation and Digitalisation Congress featured tech-savvy options for the pharmaceutical sector: AI integration and e-labelling for packaging, digital twins, AI, robotics, IoT in manufacturing, moral and human-centric AI and extra.
Supported by Merck, ESTEVE, Octapharma, GSK, Boehringer Ingelheim Pharma (as Expertise Accomplice) and EUSPA (as Innovation Accomplice), the Congress emerged as a important platform for fostering collaborations.
The primary day featured a gap panel that addressed the subject of digital applied sciences for the long run: the right way to join machines, processes and folks, in addition to the necessity for digital abilities, competencies and training. Harald Schnidar, CEO, and Avani Gupta, Enterprise Developer & Buyer Assist at SCARLETRED Holding GmbH, offered their views on the synergistic relationship between human and synthetic intelligence, pushed by AI, within the context of dermatological drug improvement.
Subsequent periods addressed affected person expertise, R&D, lab automation and manufacturing. Representatives from Automators GmbH and CNT Administration Consulting AG, Pfizer, Helbling Technik AG, Astellas, Bayer AG, Grünenthal Group and different key market gamers spoke.
Zisis Kozlakidis, the pinnacle of laboratory providers at IARC/WHO reviewed patient-centric digital interplay in public well being, highlighting the potential of built-in AI to speed up discovery, improve precision drugs and enhance public well being outcomes.
As AUTOMA+ 2025 Expertise Accomplice, Boehringer Ingelheim Pharma GmbH & Co.KG, with Joachim Bär, Director DevOps CellCulture, as speaker, offered a workshop on digital plant modelling, discussing manufacturing, innovation and sustainability.
Past the principle periods, delegates had the possibility to judge corporations’ options within the exhibition zone. Sapio Sciences displayed their LIMS techniques, Innowise highlighted AI & ML and I-care demonstrated software program for asset efficiency and predictive upkeep.
Following a day of innovation and conferences, individuals skilled relaxed networking, good delicacies and productive collaborations on the Gala Dinner in On line casino Baumgarten.
Discussions on the second day revolved round AI-powered Pharma, overlaying good provide chains, improvements in labels and packaging and digital pharma regulatory compliance. Using the pharma logistics transformation wave, GSK’s Cédric Colon, World Provide Chain Technique Programme Administration World Course of proprietor, offered why digitalisation and AI unlock provide chain worth.
As the ultimate accords of AUTOMA+ have been reached and the final phrases stated, the occasion’s magic was clear – it had united a constellation of execs decided to shift the business ahead.
In 2026, AUTOMA+ continues its digital drive subsequent in Zurich on 16-17 November: https://sh.bgs.group/3k7
Touch upon this text through X: @IoTNow_ and go to our homepage IoT Now
